EGFR and neoplasm: Survival of breast cancer patients with tumors exhibiting high overall Mena, but low Mena11a expression is significantly reduced34, 35, suggesting that Mena11a expression could antagonize mechanisms associated with tumor progression, such as the acquisition of metastasis-associated phenotypes.